APA (7th ed.) Citation

Sabbe, M., Schleich, F., Janssens, P., & Louis, R. (2024). When sequential use of mepolizumab and dupilumab in a severe atopic eosinophilic asthmatic questions the role of eosinophils in mediating the clinical expression of the disease: A case report. BMC.

Chicago Style (17th ed.) Citation

Sabbe, M., F. Schleich, P. Janssens, and R. Louis. When Sequential Use of Mepolizumab and Dupilumab in a Severe Atopic Eosinophilic Asthmatic Questions the Role of Eosinophils in Mediating the Clinical Expression of the Disease: A Case Report. BMC, 2024.

MLA (9th ed.) Citation

Sabbe, M., et al. When Sequential Use of Mepolizumab and Dupilumab in a Severe Atopic Eosinophilic Asthmatic Questions the Role of Eosinophils in Mediating the Clinical Expression of the Disease: A Case Report. BMC, 2024.